Alzheimer Disease Clinical Trials 2023

Alzheimer Disease Clinical Trials 2023

Alzheimer Disease research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in alzheimer disease clinical trials today.

Alzheimer Disease Clinical Trials

Here are the 6 most popular medical studies for alzheimer disease

Popular filter options for alzheimer disease trials

Alzheimer's Disease Clinical Trials

View 99 Alzheimer's Disease medical studies.

AD Clinical Trials

View 99 AD medical studies.

Phase 3 Alzheimer Disease Clinical Trials

View 99 phase 3 alzheimer disease medical studies.

Alzheimer Disease Clinical Trials With No Placebo

View 99 alzheimer disease medical studies that do not have a placebo group.

View More Alzheimer Disease Trials

See another 72 medical studies focused on alzheimer disease.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to alzheimer disease

What are the top hospitals conducting alzheimer disease research?

When it comes to the battle against Alzheimer's disease, several hospitals are leading the charge in groundbreaking clinical trials. The Boston Center for Memory in Newton is at the forefront with four active trials aimed at understanding and treating this complex condition. This institution has a rich history of 29 completed trials since its first recorded study in 2010. Just down the road, Massachusetts General Hospital in Boston is also heavily involved, currently conducting three Alzheimer's disease trials as part of their ongoing efforts to combat this neurodegenerative disorder. Their commitment dates back even further, with their earliest trial documented back in 1995.

In New york City, NYU Langone Health has made significant strides by initiating three current clinical trials focused on Alzheimer's disease research despite having a comparatively shorter track record—starting only in 2018—and previously holding nine dedicated studies. Down south in Delray Beach, Brain Matters Research is making substantial contributions as well; they too have three ongoing trials targeting Alzheimer’s while having successfully completed an impressive total of sixty-eight previous investigations since their pioneering trial commenced nearly two decades ago--in2003.Finally,in Fort Myers,the Neuropsychiatric Research Center of Southwest Florida rounds out this list with another trio of active clinical trials for Alzheimer's disease after recording thirty-one prior ones from starting off just over ten years ago-in2009.

These institutions signify hope not only for those affected by Alzheimer’s but also represent milestones achieved through medical advancements and tireless dedication. As we witness these top hospitals united against a formidable foe like dementia spectrum disorders,it reiterates that each patient enrolled brings us closer to unraveling new treatments and preventive measures which could positively impact countless lives around the globe

Which are the best cities for alzheimer disease clinical trials?

Miami, Florida; New york, New York; Toronto, Ontario; Indianapolis, Indiana; and Boston, Massachusetts are recognized as the best cities for Alzheimer's disease clinical trials. Miami leads with 18 active trials investigating treatments like Group A - Active Comparator, LY3372689, and Simufilam. Following closely behind is New York with 11 ongoing studies focusing on LX1001, DREEM 2 Headband, and LY3372689. Toronto ranks third with 10 active trials exploring Nabilone and Simufilam among others. Lastly, both Indianapolis and Boston offer valuable contributions to Alzheimer's research through their respective eight ongoing studies centered around interventions such as Donanemab and Gamma therapies.

Which are the top treatments for alzheimer disease being explored in clinical trials?

Exciting advancements in Alzheimer's disease research are underway, with several top treatments undergoing exploration in clinical trials. Leading the charge is LX1001, a promising intervention currently being tested in two active trials. This innovative treatment made its debut on the scene in 2019 and has already garnered attention with two all-time Alzheimer's disease trials under its belt. Another contender making waves is an Intervention technique that entered the stage in 2016 and is also participating in two ongoing trials. Additionally, researchers are investigating Blood Brain Barrier (BBB) Disruption as a potential breakthrough for this debilitating condition through two active studies since 2018. Finally, Supplemental Oxygen therapy has recently emerged on the radar with one current trial aimed at exploring its efficacy against Alzheimer's disease—marking it as an exciting avenue to watch out for moving forward.

What are the most recent clinical trials for alzheimer disease?

Recent clinical trials offer hope for individuals affected by Alzheimer's disease, a debilitating condition that impacts cognition and memory. Among these trials is RB-ADSC low dose, which has entered Phase 1 testing as of August 14th, 2023. Additionally, the experimental drug BRIV demonstrates potential in combating Alzheimer's, with its ongoing Phase 1 and Phase 2 studies since June 1st, 2023. LX1001 is another promising candidate currently undergoing Phase 1 testing after becoming available on May 8th, 2023. Furthermore, researchers are exploring the benefits of Cardio-Dance Fitness in managing symptoms associated with Alzheimer's through a Phase 2 trial launched on April11th ,2023. These efforts signify significant progress towards better understanding and treating this complex neurodegenerative disorder.

What alzheimer disease clinical trials were recently completed?

Several recent clinical trials have made significant strides in the search for effective treatments for Alzheimer's disease. In July 2022, Merck Sharp & Dohme LLC completed a trial investigating the potential of MK-8189. Additionally, Alzamend Neuro, Inc. successfully concluded their AL 001 trial in May 2022, alongside Virogenics, Inc., which finished their CMS121 trial during the same month. Furthermore, TrueBinding, Inc.'s TB006 study reached completion in October 2021 and Acumen Pharmaceuticals wrapped up their ACU193 trial in June 2021. These important advancements highlight ongoing efforts to combat Alzheimer's disease and provide hope to individuals impacted by this devastating condition.